Universal Health Realty Income Trust (UHT) opened Q1 2026 with revenue of US$24.5 million, Basic EPS of US$0.36 and net income of US$5.0 million, giving investors a clear read on how cash generation and earnings are tracking into the new year. Over recent quarters the trust has seen revenue move between US$24.5 million and US$25.7 million, while Basic EPS has ranged from US$0.29 to US$0.35. This print lands within that recent band and keeps the focus on what its margins and cash flows signal for income oriented holders.
See our full analysis for Universal Health Realty Income Trust.With the headline numbers on the table, the next step is to see how these results line up with the widely held narratives about UHT's earnings power, income appeal and risk profile, and where the data pushes back on those stories.
Curious how numbers become stories that shape markets? Explore Community Narratives
FFO of US$12.3 million keeps cash earnings steady
- Funds From Operations for Q1 2026 came in at US$12.3 million, close to the US$11.7 million to US$12.2 million range seen over the last four quarters, and trailing 12 month FFO sits at US$48.0 million.
- What stands out for a more bullish view is that cash style earnings like FFO have held around the US$47 million to US$48 million level over the last six trailing periods, even while trailing 12 month earnings per share have declined at an annualized 30.5% rate over five years. This means:
- Supporters can point to relatively steady FFO as a sign that the rental engine behind UHT’s healthcare properties is still producing cash in the US$11 million to US$12 million per quarter range.
- At the same time, critics of a bullish take can highlight that net income over the last 12 months was US$17.9 million with a 17.7% margin compared with 18.8% a year earlier, so accounting earnings and margins have been moving in a weaker direction even as FFO has been more stable.
17.7% net margin paired with 2.8% revenue growth
- Over the last 12 months, UHT generated US$100.9 million of revenue with a 17.7% net margin, compared with a prior year margin of 18.8%, while trailing revenue growth is running at 2.8% per year.
- Bears focus on this mix of modest growth and softer profitability, and the trailing data supports parts of that cautious view while also showing some resilience:
- On the cautious side, trailing 12 month earnings have declined at about 30.5% per year over five years, and revenue growth of 2.8% per year is identified as slower than the wider US market’s 11.1% pace, so top line and earnings trends are both relatively muted.
- On the more balanced side, the margin of 17.7% on just over US$100 million of revenue still represents a meaningful level of profitability, which may not fully align with the most pessimistic interpretations of a multi year earnings decline.
Premium 31.7x P/E and 7.3% dividend yield
- The units trade at a trailing P/E of 31.7x versus a peer average of 23.1x and a Global Health Care REIT industry average of 25x, while the dividend yield is 7.3% and the DCF fair value is US$43.79 versus a current price of US$40.80.
- What is interesting for a more cautious narrative is how the valuation premium and balance sheet risks stack up against the income appeal, creating a mixed set of signals:
- The higher 31.7x P/E relative to peers and industry suggests investors are paying more per dollar of trailing earnings, even though interest expense is described as not well covered by earnings. This gives bears concrete numbers to point to on both pricing and coverage risk.
- On the other hand, income oriented holders may focus on the 7.3% dividend yield and the small gap between the US$40.80 share price and the US$43.79 DCF fair value, seeing some support from cash returns and valuation work even as they weigh the weaker interest coverage.
To see how other investors are weighing this combination of a premium P/E, high yield and modest DCF upside, take a look at the community views on UHT through the 📊 Read the what the Community is saying about Universal Health Realty Income Trust.
Next Steps
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Universal Health Realty Income Trust's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
If this mix of income appeal, valuation and risk feels finely balanced, it is a good time to check the details yourself and move quickly while the data is fresh. To see how the current numbers translate into concrete upsides and concerns, take a closer look at the 2 key rewards and 2 important warning signs.
See What Else Is Out There
UHT combines slower 2.8% revenue growth, softer margins and weaker interest coverage with a relatively high 31.7x P/E, which can leave valuation-focused investors uneasy.
If that mix feels a little rich for the risks on show, it is worth immediately checking companies that line up better on value and balance sheet strength using the solid balance sheet and fundamentals stocks screener (43 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com